Candel Therapeutics (CADL) EBT Margin (2020 - 2022)
Candel Therapeutics (CADL) reported EBT Margin of 27480.65% for Q4 2022, up 40725269.0% on a YoY basis from N/an in Q4 2021, and up 5.94% sequentially from 29216.13% in Q3 2022.
Candel Therapeutics (CADL) EBT Margin (2020 - 2022) Analysis & Trends
Candel Therapeutics (CADL) has 3 years of EBT Margin data on file, last reported at 27480.65% in Q4 2022.
- For the quarter ending Q4 2022, EBT Margin rose 40725269.0% year-over-year to 27480.65%; the trailing twelve-month figure through Dec 2022 stood at 52295.16% (down 788405.0% YoY), and the FY2022 full-year result was 51072.0%, down 2900.0% from the prior year.
- EBT Margin improved to 27480.65% in Q4 2022, from 29216.13% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 7458.06% in Q2 2020 to a low of 434733.33% in Q4 2021.
- A 3-year average of 70370.19% and a median of 27480.65% in 2022 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin tumbled 37860108 bps in 2021 and jumped 40725269 bps in 2022, its largest moves.
- Tracing CADL's EBT Margin over 3 years: stood at 56132.26% in 2020, then sank by 674 bps to 434733.33% in 2021, then jumped by 94 bps to 27480.65% in 2022.
- Business Quant data shows CADL's EBT Margin at 27480.65% in Q4 2022, 29216.13% in Q3 2022, and 29412.9% in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Candel Therapeutics | 542.51 Mn | 542.51 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -27,480.65% |
| Sep 30, 2022 | -29,216.13% |
| Jun 30, 2022 | -29,412.90% |
| Mar 31, 2022 | -123,070.97% |
| Dec 31, 2021 | -434,733.33% |
| Sep 30, 2021 | -25,477.42% |
| Jun 30, 2021 | -17,148.39% |
| Mar 31, 2021 | -15,061.29% |
| Dec 31, 2020 | -56,132.26% |
| Sep 30, 2020 | -8,880.65% |
| Jun 30, 2020 | -7,458.06% |